Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

Effect of Roxadustat on Cardiometabolism Recruiting

2023-508183-29-00 Risk factors of cardiovascular disease 6 2024-08-07
COMPARE STEMI ONE- Comparison Of reduced DAPT followed by P2Y12 inhibitor Monotherapy with Prasugrel vs stAndard Regimen in STEMI patients t… Recruiting

2024-515883-30-00 St-Elevated Myocardial Infartion 6 2024-08-01
Preventing caRdiovascular collapsE with VasoprEssors duriNg Tracheal IntubatiON: The PREVENTION Randomized Controlled Trial (PREVENTION tria… Recruiting

2023-503895-25-00 criticall illness 5 2024-08-01
Trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant a… Recruiting

2023-504169-22-02 Severe cardiac inflammation 5 2024-07-31
CLEAR-PATH trial Recruiting

2024-513363-15-01 (Chronic) Peripheral (occlusive) arterial disease (PAD) 11 2024-07-22
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing Recruiting

2023-509905-62-00 Lower limb trauma requiring immobilisation 5 2024-07-19
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on… Recruiting

2022-502135-19-00 Calcific Aortic Valve Stenosis 4 2024-07-18
Beneficial effects of vitamin D combined with oral iron supplementation in patients with chronic heart failure and iron deficiency (VICTORID… Recruiting

2024-519878-39-00 Chronic heart failure; iron deficiency 6 2024-07-12
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Beta-Blockers in Takotsubo Syndrome: A Randomized Clinical Trial Recruiting

2023-510213-25-01 Takotsubo Syndrome (TT) is an acute cardiac condition 6 2024-07-08
New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting

2023-505794-32-04 Type 1 diabetes 5 2024-07-05
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator … Recruiting

2023-508024-36-00 Cardiogenic Shock 4 2024-07-05
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induc… Recruiting

2024-514880-25-00 Patients with cardiovascular alterations induced by cir 5 2024-06-27
Pragmatic clinical trial to assess the utility of SLCO1B1, ABCG2, and CYP2C9 preemtive genotyping and pharmacogenetics training on the incid… Recruiting

2023-506814-31-01 Cardiovascular risk which needs primary or secundary pr 6 2024-06-25
Impact of local tissue inflammation on intramyocardial conduction pathways post percutaneous valve : evaluation by positron emission tomogra… Recruiting

2024-514587-44-00 Aortic stenosis 4 2024-06-17
Comparing Anticoagulation Strategies using Unfractionated heparin, Argatroban and Low-molecular-weight heparin for Extracorporeal Membrane (… Recruiting

2024-518702-40-00 Respiratory Insufficiency, Respiratory Failure, Circula 6 2024-06-17
Carvedilol vs. flecainida clinical trial in idiopathic ventricular arrhythmias. Recruiting

2023-510362-26-00 Idiopathic ventricular arrhythmias 6 2024-06-11
StAtins for Venous Event Reduction in Patients with Venous Thromboembolism : The SAVER Trial Recruiting

2023-504486-23-00 Venous thromboembolism 5 2024-05-29
Beta receptor modulation trial in cardiogenic shock patients supported by V-A ECMO Recruiting

2024-511805-42-00 Cardiogenic shock 4 2024-05-23
PROMISE Recruiting

2023-505626-34-01 Chronic kidney disease 6 2024-05-16
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) Recruiting

2022-500319-38-00 Paroxysmal supraventricular tachycardia (PSVT) 4 2024-05-03
Dapagliflozin in patients with Right Heart Failure (Dapa-RHF) Recruiting

2024-515044-23-01 Chronic right heart failure 4 2024-04-29
Sacubitril/Valsartan in prevention of heart damage during breast cancer treatment Recruiting

2024-517804-12-00 Heart failure – post-anthracycline cardiomyopathy 5 2024-04-17